1220482

Fresenius Kabi USA, LLC — FEI 3001833549

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 13, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Grand Island, NY (United States)

Citations

IDCFRDescription
145121 CFR 211.113(b)Procedures for sterile drug products
202721 CFR 211.192Investigations of discrepancies, failures